In a study using an IκBα inhibitor in breast cancer cells, it was shown that the increase in HO-1 expression activated the ferroptotic pathway through release of iron from degradation of heme and deregulation of iron transport proteins [33]. Here, HMOX1 is linked to breast carcinoma.